Streetbeat News

Price Targets

GWW

UBS analyst Joseph Parkhill has downgraded W.W. Grainger (NYSE:GWW) from Buy to Neutral, while raising the price target from $815 to $820.

Portfolio Pulse from richadhand@benzinga.com

July 12, 2023 | 10:28 am

CACI

Jefferies analyst Amit Singh has upgraded CACI International (NYSE:CACI) from Hold to Buy and announced a price target of $405.

Portfolio Pulse from richadhand@benzinga.com

July 12, 2023 | 10:27 am

DKNG

B of A Securities analyst Shaun Kelley has upgraded DraftKings (NASDAQ:DKNG) from Neutral to Buy and announced a $35 price target.

Portfolio Pulse from richadhand@benzinga.com

July 12, 2023 | 10:26 am

HLLY

B of A Securities analyst Alexander Perry has upgraded Holley (NYSE:HLLY) from Neutral to Buy and raised the price target from $3.25 to $6.

Portfolio Pulse from richadhand@benzinga.com

July 12, 2023 | 10:25 am

TJX

Loop Capital analyst Laura Champine has upgraded TJX Companies from Hold to Buy and raised the price target from $75 to $95.

Portfolio Pulse from richadhand@benzinga.com

July 12, 2023 | 10:23 am

RICK

HC Wainwright & Co. analyst Scott Buck maintains a 'Buy' rating on RCI Hospitality Hldgs (NASDAQ:RICK) but lowers the price target from $140 to $126.

Portfolio Pulse from richadhand@benzinga.com

July 12, 2023 | 10:11 am

EVO

HC Wainwright & Co. analyst Douglas Tsao has reiterated a 'Buy' rating on Evotec (NASDAQ:EVO) and maintained a $12 price target.

Portfolio Pulse from richadhand@benzinga.com

July 12, 2023 | 10:10 am

IPA

HC Wainwright & Co. analyst Swayampakula Ramakanth has reiterated a 'Buy' rating on ImmunoPrecise Antibodies (NASDAQ:IPA) and maintained a $9 price target.

Portfolio Pulse from richadhand@benzinga.com

July 12, 2023 | 10:09 am

ANIX

HC Wainwright & Co. analyst Yi Chen has reiterated a 'Buy' rating on Anixa Biosciences (NASDAQ:ANIX) and maintained a $12 price target.

Portfolio Pulse from richadhand@benzinga.com

July 12, 2023 | 10:07 am

EXK

HC Wainwright & Co. analyst Heiko Ihle maintains a 'Buy' rating on Endeavour Silver (NYSE:EXK) and raises the price target from $5.5 to $8.

Portfolio Pulse from richadhand@benzinga.com

July 12, 2023 | 10:04 am